<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39351259</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-6128</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in fungal biology</Title><ISOAbbreviation>Front Fungal Biol</ISOAbbreviation></Journal><ArticleTitle>Editorial: Co-morbidity of COVID 19 and fungal infections.</ArticleTitle><Pagination><StartPage>1462172</StartPage><MedlinePgn>1462172</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1462172</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/ffunb.2024.1462172</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Ramendra Pati</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>School of Health Sciences and Technology (SoHST), UPES, Dehradun, Uttarakhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhiman</LastName><ForeName>Ruby</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Health Sciences and Technology (SoHST), UPES, Dehradun, Uttarakhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Vivek</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Amity Institute of Click-Chemistry Research and Studies (AICCRS), Amity University Uttar Pradesh, Noida, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>V Samuel</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Centre for Drug Design Discovery and Development (C4D), SRM University, Sonepat, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chung-Ming</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Master &amp; Ph.D. Program in Biotechnology Industry, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Fungal Biol</MedlineTA><NlmUniqueID>9918266300506676</NlmUniqueID><ISSNLinking>2673-6128</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Editorial on the Research Topic Co-morbidity of COVID 19 and fungal infections</RefSource></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">clinical management</Keyword><Keyword MajorTopicYN="N">co-morbidity</Keyword><Keyword MajorTopicYN="N">fungal infections</Keyword><Keyword MajorTopicYN="N">morbidity and mortality</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39351259</ArticleId><ArticleId IdType="pmc">PMC11439790</ArticleId><ArticleId IdType="doi">10.3389/ffunb.2024.1462172</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dutt Y., Pandey R. P., Dutt M., Gupta A., Vibhuti A., Raj V. S., et al. . (2023). Silver Nanoparticles Phytofabricated through Azadirachta indica: Anticancer, Apoptotic, and Wound-Healing Properties. Antibiotics (Basel). 12, 121. doi: 10.3390/antibiotics12010121</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12010121</ArticleId><ArticleId IdType="pmc">PMC9855199</ArticleId><ArticleId IdType="pubmed">36671322</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutt Y., Pandey R. P., Dutt M., Gupta A., Vibhuti A., Raj V.S., et al. . (2023). Liposomes and phytosomes: Nanocarrier systems and their applications for the delivery of phytoconstituents. Coordination Chem. Rev. 491, 215251. doi: 10.1016/j.ccr.2023.215251</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2023.215251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hameed S., Hans S., Singh S., Dhiman R., Monasky R., Pandey R. P., et al. . (2021). Revisiting the vital drivers and mechanisms of β-glucan masking in human fungal pathogen, candida albicans . Pathogens 10, 942. doi: 10.3390/pathogens10080942</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10080942</ArticleId><ArticleId IdType="pmc">PMC8399646</ArticleId><ArticleId IdType="pubmed">34451406</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey R. P., Nascimento M. S., Moore C. E., Raj V. S., Kalil J., Cunha-Neto E. (2021). New approaches for the treatment of chagas disease. Curr. Drug Targets. 22, 835–841. doi: 10.2174/1389450121999201124122643</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450121999201124122643</ArticleId><ArticleId IdType="pubmed">33238855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruby M., Gifford C. C., Pandey R., Raj V. S., Sabbisetti V. S., Ajay A. K. (2023). Autophagy as a therapeutic target for chronic kidney disease and the roles of TGF-β1 in autophagy and kidney fibrosis. Cells 12, 412. doi: 10.3390/cells12030412</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12030412</ArticleId><ArticleId IdType="pmc">PMC9913737</ArticleId><ArticleId IdType="pubmed">36766754</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadhu S., Rizvi Z. A., Pandey R. P., Dalal R., Rathore D. K., Kumar B., et al. . (2021). Gefitinib results in robust host-directed immunity against salmonella infection through proteo- metabolomic reprogramming. Front. Immunol. 12, 648710. doi: 10.3389/fimmu.2021.648710</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.648710</ArticleId><ArticleId IdType="pmc">PMC8044459</ArticleId><ArticleId IdType="pubmed">33868285</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi R., Srivastava M., Jain P., Pandey R. P., Asthana S., Kumar D., et al. . (2022). Development of potential proteasome inhibitors against Mycobacterium tuberculosis. J. Biomol Struct. Dyn 40, 2189–2203. doi: 10.1080/07391102.2020.1835722</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1835722</ArticleId><ArticleId IdType="pubmed">33074049</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>